NEWS COMMENTARY

DSM and Cargill join forces to bring fermentation-based stevia to the market

Published:
November 9, 2018
Coverage:
Accelerating Materials Innovation More...
Activities:
Partnership More...
12616 thumb square
by Harini Venkataraman
Very important

DSM and Cargill recently announced a joint venture (JV), "Avansya," to commercialize next-generation stevia rebaudiosides Reb M and Reb D. As a part of this 50-50 JV, the companies hope to combine DSM's strain development expertise and Cargill's large-scale fermentation capacity to bring fermentation-based rebaudiosides to the market under the "EverSweet" brand. The exact details of this JV will be finalized by Q1 2019. Currently, it remains unclear how this JV will affect Cargill's previous licensing agreement with Evolva, but Cargill's commercialization timeline was significantly delayed due to problems with strain optimization. Clients should note that this JV is likely to expedite the launch of the fermentation-derived stevia product.

For the original news article, click here .


Further Reading

Stevia is back in the limelight with recent announcements

News Commentary | July 16, 2018

Earlier this year, we outlined the key developments to look for in stevia production innovation. One of those is the large‑scale production of rebaudioside M (Reb M). DSM recently launched its Reb M product "AVANSYA" for food and beverage applications. Coincidentally, PureCircle, another major ... Not part of subscription

Genomatica

Company Profile | April 12, 2018

Combines predictive computational modeling tools, microorganism design and development, and process engineering to develop fermentation‑based production routes; modeling of the fermentation process decreases the amount of test runs before scale‑up, reducing the time and cost to develop new ... Not part of subscription

Genomatica partners with Bio-Botanica to create botanical extracts using its bio-based butylene glycol

News Commentary | April 30, 2018

Genomatica recently announced a partnership with Bio‑Botanica to utilize its 1,3‑butylene glycol (1,3‑BG), which was developed and scaled in stealth to 85,000 L fermenters in August 2017, to create a new line of botanical extracts. The first of these extracts will be showcased at NYSCC Suppliers' ... Not part of subscription